STAT Plus: Pharmalittle: AstraZeneca pauses its Covid-19 vaccine trial; FDA sticking with its vaccine approval guidelines
Rise and shine, everyone, another busy day is on the way. Our first clue is that the short person has left summer behind and is now stationed in front of a laptop for remote learning. And since the official mascot has successfully completed his morning calisthenics, we are free to get cracking. Toward that end, we are firing up the coffee kettle and examining our to-do list. Meanwhile, here are a few items of interest. We hope your journey today is productive and, as always, do keep in touch. We appreciate the feedback and juicy tips. …
A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca (AZN) and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom, STAT reports. AstraZeneca initiated the study hold. The nature of the adverse reaction and when it happened were not immediately known, but the participant is expected to recover.
Continue to STAT Plus to read the full story…
